Back to FDA Applications sponsored by ALCON PHARMS LTD

FDA Drug Application 021862 by ALCON PHARMS LTD

Application Number021862
Application Type New Drug Application
Sponsor ApplicantALCON PHARMS LTD
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Priority
Orphan Code 


  
Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP08/19/2005N12651000   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021862ltr.pdf 8/23/2005
AP08/19/2005N12655000   http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021862lbl.pdf 8/23/2005
AP08/19/2005N12837000   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/021862s000_NevanacTOC.cfm 10/6/2005
AP05/8/2008SLR19988002   http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021862s002lbl.pdf 6/12/2008
AP06/27/2011SLR29300008   http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021862s008lbl.pdf 6/27/2011
AP06/27/2011SLR29383008   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021862s008ltr.pdf 7/5/2011
AP03/7/2014SCM       




Back to FDA Applications sponsored by ALCON PHARMS LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.